Contraceptive use of antiprogestin

European Journal of Contraception and Reproductive Health Care

Volumn 4, Issue 2, 1999, Pages 103-107

  Bygdeman, M ^a   Gemzell Danielsson, K ^a   Marions, L ^a   Swahn, M L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiprogestin; Contraception; Menstrual cycle; Mifepristone; Ovulation inhibition

Indexed keywords

ANTIGESTAGEN; MIFEPRISTONE;

CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENDOMETRIUM; FEMALE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OVARY FUNCTION; OVULATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEXUAL INTERCOURSE;

EID: 0033047871     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189909064011     Document Type: Review

References (24)

1. Bygdeman M, Swahn ML. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 1985; 32: 45-51
2. Ulmann A, Silvestre L, Chemama L, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Acta Obstet Gynecol Scand 1992; 71: 278-83
3. Liu JH, Garzo G, Monis Strenkel C, Ulmann A, Yen SCC. Disruption of follicular maturation and delay of ovulation after administration of the antiprogestin RU 486. J Clin Endocrinol Metab 1987; 65: 1135-40
4. Luukainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertil Steril 1988; 49: 361-3
5. Shoupe D, Mishell DR, Page MA, Madkour H, Spitz JM, Lobo RA. Effects of the antiprogesterone RU 486 in normal follicular phase. Am J Obstet Gynecol 1987; 157: 1421-6
6. Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M. The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Hum Reprod 1988; 3: 915-21
7. Puri CP, Patel RK, Elger AG, Vadigoppula AD, Pongula JMR. Gonadal and pituitary responses to progesterone antagonist ZK 98,299 during the follicular phase of the menstrual cycle in bonnet monkeys. Contraception 1989; 39: 227-43
8. Kekkonen R, Croxatto HB, Lähteenmäki P, Salvatierra AM, Tuominen J. Effects of intermittent antiprogestin RU 486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation. Hum Reprod 1995; 10: 287-92
9. Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Merriam GR, Loriaux DL. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J Clin Endocrinol Metab 1992; 74: 565-70
10. Batista MC, Cartledge TP, Zeilmer AW, Nieman LK, Loriaux DL, Merriam GR. The antiprogesterone RU 486 delays the midcycle gonadotrophin surge and ovulation in gonadotrophin-releasing hormone induced cycles. Fertil Steril 1994; 62: 28-34
11. Gemzell Danielsson K, Svalander P, Swahn ML, Johannisson E, Bygdeman M. Effect of a single postovulatory dose of RU 486 on the endometrial maturation in the implantation phase. Hum Reprod 1994; 9: 2398-404
12. Swahn ML, Bygdeman M, Xing S, Cekan S, Masironi B, Johannisson E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum Reprod 1990; 5: 402-8
13. Li T-C, Dockery P, Thomas P, Rogers AW, Lenton EA, Cooke ID. The effects of progesterone blockade in the luteal phase of normal fertile women. Fertil Steril 1988; 50: 732-42
14. 2α concentrations. Hum Reprod 1994; 9: 1626-30
15. Mäentausta O, Svalander P, Gemzell-Danielsson K, Bygdeman M, Vikho R. The effects of an antiprogesterone, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17β-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle. An immunohistochemical study. J Endocrinol Metab 1993; 77: 913-18
16. Gemzell Danielsson K, Swahn ML, Bygdeman M. The effect of various doses of mifepristone on leukaemia inhibitory factor expression in the midluteal phase - An immunohistochemical study. Hum Reprod 1997; 12: 1293-7
17. Marions L, Gemzell Danielsson K, Bygdeman M. The effect of antiprogestin in integrin expression in human endometrium. An immunohistochemical study. Hum Reprod 1998; 4: 491-5
18. Gemzell Danielsson K, Westlund P, Johannisson E, Swahn ML, Seppälä M, Bygdeman M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod 1997; 12: 124-31
19. Gemzell Danielsson K, Swahn ML, Svalander P, Bygdeman M. Early luteal phase treatment with RU 486 for fertility regulation. Hum Reprod 1993; 8: 870-3
20. Glasier AF, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progesterone emergency postcoital contraception. N Engl J Med 1992; 327: 1041-4
21. Webb AMC, Russel J, Elstein M. Comparison of Yuzpe regimen, danazol and mifepristone (RU 486) in oral postcoital contraception. Br Med J 1992; 305: 927-31
22. Marions L, Gemzell Danielsson K, Swahn ML, Bygdeman M. Contraceptive efficacy of low doses of mifepristone. Fertil Steril 1998; 70: 813-16
23. WHO Task Force on Methods for the Determination of the Fertile Period. A prospective multicentre trial of the ovulation method of natural family planning. III. Characterization of the menstrual cycle and the fertile phase. Fertil Steril 1983; 40: 773-8
24. Wilcox AJ, Weinberg CR, Baird DT. Timing of sexual intercourse in relation to ovulation. N Engl J Med 1995; 333: 1517-21